AlgoDynamix partners with Quant pioneer Dr. Ernie Chan for new Crypto related product developments
London, Cambridge (UK), Toronto and Niagara-on-the-Lake (Canada) September 8, 2022: AlgoDynamix, the leader in behavioral based price forecasting for financial markets has signed a collaboration agreement with Quant pioneer Dr. Ernie Chan. The agreement covers research, development and productization with a strong initial focus on Crypto. New investment products are expected to be available early Q4 2022.
By: AlgoDynamix (UK) Ltd.
Dr. Ernie Chan, "Crypto is a great asset class with lots of potential, though as we have seen in the past few months it can be very challenging!"
Throughout the last three decades Dr. Chan has transformed the financial services industry using his mathematical rigor. This already started back in the days of his IBM research and continued with ongoing research at the bulge bracket investment banks as well as the smaller more efficient hedge funds. His latest venture includes advanced predictive analytics and partnerships that maximize his decades of multi-asset trading, tail risk management, portfolio construction and flawless trade execution.
Tarun Khanna, President AlgoDynamix North America: "We are absolutely delighted to be working with Dr. Ernie Chan on groundbreaking new Crypto investment products. Our initial discussions with Dr. Chan made it clear that there was definitely an opportunity to work together and to combine the best of all worlds."
Updates and further announcements will be available throughout Q4, please do join AlgoDynamix mailing list for latest updates.
Press releases and website disclaimers
Home - AlgoDynamix (UK) overview @ Amadeus Capital Partners
About Dr. Ernest P. Chan
Home - E.P. Chan & Associates (epchan.com)